Skip to main content
. 2023 Jan 16;12:1082062. doi: 10.3389/fonc.2022.1082062

Figure 2.

Figure 2

Histopathological and molecular findings of a representative diffuse midline glioma, H3 K27-altered (WHO 2021). (A) Hematoxylin and eosin image (original magnification: 100X) showing a diffuse, infiltrative glioma with astrocytic morphology. (B) Diffuse expression of OLIG2, a glial marker, is consistent with this tumor type. (C) Loss of H3K27me3 is present and exemplifies a mandatory diagnostic feature. (D) Sanger sequencing output showing a K27M mutation (arrow), the most frequent molecular alteration observed in this tumor type.